News

Filter

Topic: Neurology Department

February 10, 2020
Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicates
Top-line data reported from international trial.
News Release
February 5, 2020
Gene ID’d as potential therapeutic target for dementia in Parkinson’s
Targeting gene linked to Alzheimer’s may reduce dementia risk in Parkinson’s.
News Release
January 16, 2020
$29 million for new phase of international Alzheimer’s study
Research focuses on precisely how the disease develops in the brain.
News Release
January 6, 2020
Miller receives international innovation prize
Recognized for developing experimental treatment for ALS.
National Leaders
December 17, 2019
Hogan elected officer of American Epilepsy Society
Expert on neuroimaging, pharmacological treatment of epilepsy.
National Leaders
December 10, 2019
Why doesn’t deep-brain stimulation work for everyone?
Personalized brain maps could improve treatment for Parkinson's disease, other neurological conditions.
News Release
November 19, 2019
Major Alzheimer’s study to open 5 new Latin American sites
Expansion will shed light on Alzheimer’s disease in Latino populations.
News Release
November 19, 2019
Importante estudio en enfermedad de Alzheimer abrirá 5 nuevos sitios latinoamericanos
Los nuevos sitios aportarán relevantes datos sobre la enfermedad de Alzheimer en las poblaciones latinas.
November 13, 2019
Kipnis named BJC Investigator
Leader in groundbreaking research on interaction of brain and immune system to join faculty.
News Release
October 22, 2019
Dementia patients’ adult kids diagnosed earlier than their parents
Unknown genetic factors may affect when symptoms arise.
News Release
October 10, 2019
Targeting immune cells may be potential therapy for Alzheimer’s
Mouse study shows immune cells drive brain damage.
News Release, Video
October 4, 2019
Alzheimer’s research reset
Source: Science Magazine
October 1, 2019
Gutmann wins prestigious neuro-oncology prize
Honored for work on pediatric brain tumors.
National Leaders
September 27, 2019
Holtzman awarded Watanabe Prize in Translational Research
Recognized for developing potential therapies for Alzheimer’s disease.
National Leaders
August 15, 2019
Antisense drugs for Huntington’s, ALS and prion diseases could meet the dire need for brain treatments
Source: Scientific American
August 14, 2019
Genes linked to Alzheimer’s risk, resilience ID’d
Genes in the brain’s immune cells may point to strategy to protect against the disease.
News Release
August 1, 2019
A blood test for Alzheimer’s? It’s coming, scientists report
Source: New York Times
August 1, 2019
Blood test is highly accurate at identifying Alzheimer’s before symptoms arise
When combined with age and genetic risk factor, test is 94% accurate.
News Release
July 19, 2019
Excluding minorities from Alzheimer’s research is wrong – and it’s keeping us from finding a cure
Source: Quartz
July 8, 2019
Cross honored for multiple sclerosis research
Recognized for role in discovering destructive effects of immune B cells in MS.
National Leaders
June 26, 2019
Understanding how tics are suppressed may help some at risk for tic disorders
Identifying kids who control their tics may help others at risk for Tourette syndrome.
News Release
June 24, 2019
Alzheimer’s missing link ID’d, answering what tips brain’s decline
Brain’s immune cells form nexus between two damaging Alzheimer’s proteins.
News Release
May 29, 2019
Immune cells determine how fast certain tumors grow
Study suggests new approaches to treating NF1 brain tumors.
News Release
May 3, 2019
Physical therapy association honors Earhart
Named a Catherine Worthingham Fellow, the group's highest honor.
National Leaders